CLIA lab

CLIA 15D2211894: Phillips Drugs Inc

Richmond, IN. Certificate and address details from the CMS Provider of Services file for clinical laboratories.

CLIA number 15D2211894 belongs to Phillips Drugs Inc in Richmond, IN.

Certificate of Waiver, effective February 1, 2025, expires January 31, 2027.

Active in the CMS Provider of Services file posted October 16, 2026.

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Run it in Rivvi

Map your lab's test names to LOINC codes

Open in Rivvi

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Certificate

Certificate type
Certificate of Waiver
Certificate effective
February 1, 2025
Certificate expiration
January 31, 2027
Status in the CMS file
Active (termination code 00)
Original participation date
February 1, 2021
Facility type
Pharmacy
Ownership (control type)
Proprietary
Lab classification
CLIA laboratory
Directly affiliated labs
1

Source: CMS Provider of Services File, Clinical Laboratories (CLIA), as of October 16, 2026. Publisher page

Lab and contact

CLIA number
15D2211894
Lab name
Phillips Drugs Inc
Address
631 E Main Street, Richmond, IN 47374
Phone
(765) 966-5544

Annual test volume the lab reported

Waived tests
150

Volumes are what the lab reported to CMS on its CMS-116 application, as carried in the file.

Affiliated CLIA numbers

Other labs in Richmond, IN

Related

Questions

What is the CLIA number for Phillips Drugs Inc in Richmond?

15D2211894, per the CMS Provider of Services file posted October 16, 2026.

What CLIA certificate does Phillips Drugs Inc hold?

A Certificate of Waiver, according to the CMS file.

When does CLIA 15D2211894 expire?

The CMS file lists January 31, 2027 as the certificate expiration date; the certificate took effect February 1, 2025.

Try it on your own data today.

Free to start. Most teams are using it the same day.